{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:11:22Z","timestamp":1794507082974,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancers are characterized by reprogrammed glucose metabolisms to fuel cell growth and proliferation. Carbohydrate response element\u00a0binding protein (ChREBP) is a glucose-mediated transcription factor that strongly regulates glycolytic and lipogenic pathways. It has been shown to associate with metabolic diseases, such as obesity, diabetes and non-alcoholic fatty liver diseases. However, how it associates with cancers has not been well understood. In this study, ChREBP expression was assessed by immunohistochemistry in colon tissue arrays containing normal colon tissue and cancer tissue at different clinical stages. Tissue mRNA levels of ChREBP were also measured in a cohort of colon cancer patients. We found that ChREBP mRNA and protein expression were significantly increased in colon cancer tissue compared to healthy colon (p\u2009&lt;\u20090.001), and their expression was positively correlated to colon malignancy (for mRNA, p\u2009=\u20090.002; for protein p\u2009&lt;\u20090.001). Expression of lipogenic genes (<jats:italic>ELOVL6<\/jats:italic> and <jats:italic>SCD1<\/jats:italic>) in colon cancer was also positively associated with colon malignancy (for both genes, p\u2009&lt;\u20090.001). <jats:italic>In vitro<\/jats:italic>, ChREBP knockdown with siRNA transfection inhibited cell proliferation and induced cell cycle arrest without changes in apoptosis in colon cancer cell lines (HT29, DLD1 and SW480). Glycolytic and lipogenic pathways were inhibited but the p53 pathway was activated after ChREBP knockdown. Taken together, ChREBP expression is associated with colon malignancy and it might contribute to cell proliferation via promoting anabolic pathways and inhibiting p53. In addition, ChREBP might represent a novel clinical useful biomarker to evaluate the malignancy of colon cancer.<\/jats:p>","DOI":"10.1038\/s41598-020-60903-9","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T11:02:37Z","timestamp":1583492557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation"],"prefix":"10.1038","volume":"10","author":[{"given":"Yu","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"60903_CR1","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1073\/pnas.0401516101","volume":"101","author":"K Iizuka","year":"2004","unstructured":"Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D. & Uyeda, K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc. Natl Acad. Sci. USA 101, 7281\u20137286, https:\/\/doi.org\/10.1073\/pnas.0401516101 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60903_CR2","doi-asserted-by":"publisher","first-page":"9116","DOI":"10.1073\/pnas.161284298","volume":"98","author":"H Yamashita","year":"2001","unstructured":"Yamashita, H. et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl Acad. Sci. USA 98, 9116\u20139121, https:\/\/doi.org\/10.1073\/pnas.161284298 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60903_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/hmg\/10.6.617","volume":"10","author":"S Cairo","year":"2001","unstructured":"Cairo, S., Merla, G., Urbinati, F., Ballabio, A. & Reymond, A. WBSCR14, a gene mapping to the Williams\u2013Beuren syndrome deleted region, is a new member of the Mlx transcription factor network. Hum. Mol. Genet. 10, 617\u2013627 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"60903_CR4","doi-asserted-by":"publisher","first-page":"15597","DOI":"10.1073\/pnas.0405238101","volume":"101","author":"S Ishii","year":"2004","unstructured":"Ishii, S., Iizuka, K., Miller, B. C. & Uyeda, K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl Acad. Sci. USA 101, 15597\u201315602, https:\/\/doi.org\/10.1073\/pnas.0405238101 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60903_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2010.04.028","volume":"395","author":"MV Li","year":"2010","unstructured":"Li, M. V. et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochemical biophysical Res. Commun. 395, 395\u2013400, https:\/\/doi.org\/10.1016\/j.bbrc.2010.04.028 (2010).","journal-title":"Biochemical biophysical Res. Commun."},{"key":"60903_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jhep.2011.07.019","volume":"56","author":"R Dentin","year":"2012","unstructured":"Dentin, R. et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J. hepatology 56, 199\u2013209, https:\/\/doi.org\/10.1016\/j.jhep.2011.07.019 (2012).","journal-title":"J. hepatology"},{"key":"60903_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/Bj20111280","volume":"443","author":"C Arden","year":"2012","unstructured":"Arden, C. et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochemical J. 443, 111\u2013123, https:\/\/doi.org\/10.1042\/Bj20111280 (2012).","journal-title":"Biochemical J."},{"key":"60903_CR8","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1172\/JCI41624","volume":"120","author":"J Bricambert","year":"2010","unstructured":"Bricambert, J. et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 120, 4316\u20134331, https:\/\/doi.org\/10.1172\/JCI41624 (2010).","journal-title":"J. Clin. Invest."},{"key":"60903_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/db10-0452","volume":"60","author":"C Guinez","year":"2011","unstructured":"Guinez, C. et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60, 1399\u20131413, https:\/\/doi.org\/10.2337\/db10-0452 (2011).","journal-title":"Diabetes"},{"key":"60903_CR10","doi-asserted-by":"publisher","first-page":"E788","DOI":"10.1152\/ajpendo.00510.2006","volume":"292","author":"KB Pedersen","year":"2007","unstructured":"Pedersen, K. B. et al. The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions. Am. J. physiology. Endocrinol. Metab. 292, E788\u2013801, https:\/\/doi.org\/10.1152\/ajpendo.00510.2006 (2007).","journal-title":"Am. J. physiology. Endocrinol. Metab."},{"key":"60903_CR11","doi-asserted-by":"publisher","first-page":"38719","DOI":"10.18632\/oncotarget.5340","volume":"6","author":"R Sanchez-Martinez","year":"2015","unstructured":"Sanchez-Martinez, R. et al. A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy. Oncotarget 6, 38719\u201338736, https:\/\/doi.org\/10.18632\/oncotarget.5340 (2015).","journal-title":"Oncotarget"},{"key":"60903_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann, L. P. et al. The interaction of hepatic lipid and glucose metabolism in liver diseases. J. hepatology 56, 952\u2013964, https:\/\/doi.org\/10.1016\/j.jhep.2011.08.025 (2012).","journal-title":"J. hepatology"},{"key":"60903_CR13","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci, E. et al. Diabetes and cancer: a consensus report. Diabetes care 33, 1674\u20131685, https:\/\/doi.org\/10.2337\/dc10-0666 (2010).","journal-title":"Diabetes care"},{"key":"60903_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/sj.ijo.0800561","volume":"22","author":"BJ Caan","year":"1998","unstructured":"Caan, B. J. et al. Body size and the risk of colon cancer in a large case-control study. Int. J. Obes. Relat. Metab. disorders: J. Int. Assoc. Study Obes. 22, 178\u2013184 (1998).","journal-title":"Int. J. Obes. Relat. Metab. disorders: J. Int. Assoc. Study Obes."},{"key":"60903_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1470-2045(02)00849-5","volume":"3","author":"F Bianchini","year":"2002","unstructured":"Bianchini, F., Kaaks, R. & Vainio, H. Overweight, obesity, and cancer risk. Lancet. Oncol. 3, 565\u2013574 (2002).","journal-title":"Lancet. Oncol."},{"key":"60903_CR16","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","volume":"66","author":"JW Kim","year":"2006","unstructured":"Kim, J. W. & Dang, C. V. Cancer\u2019s molecular sweet tooth and the Warburg effect. Cancer Res. 66, 8927\u20138930, https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1501 (2006).","journal-title":"Cancer Res."},{"key":"60903_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gde.2009.01.002","volume":"19","author":"X Tong","year":"2009","unstructured":"Tong, X., Zhao, F. & Thompson, C. B. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr. Opin. Genet. Dev. 19, 32\u201337, https:\/\/doi.org\/10.1016\/j.gde.2009.01.002 (2009).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"60903_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311\u2013321, https:\/\/doi.org\/10.1016\/j.ccr.2005.09.008 (2005).","journal-title":"Cancer Cell"},{"key":"60903_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nat. 452, 230\u2013U274, https:\/\/doi.org\/10.1038\/nature06734 (2008).","journal-title":"Nat."},{"key":"60903_CR20","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","volume":"66","author":"FP Kuhajda","year":"2006","unstructured":"Kuhajda, F. P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 66, 5977\u20135980, https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4673 (2006).","journal-title":"Cancer Res."},{"key":"60903_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/bjc.2013.765","volume":"110","author":"RE Airley","year":"2014","unstructured":"Airley, R. E. et al. Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression. Brit J. Cancer 110, 715\u2013723, https:\/\/doi.org\/10.1038\/bjc.2013.765 (2014).","journal-title":"Brit J. Cancer"},{"key":"60903_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140, 1071\u20131083, https:\/\/doi.org\/10.1053\/j.gastro.2010.12.006 (2011).","journal-title":"Gastroenterology"},{"key":"60903_CR23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004099","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Myc and ChREBP Transcription Factors Cooperatively Regulate Normal and Neoplastic Hepatocyte Proliferation in Mice. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.RA118.004099 (2018).","journal-title":"J. Biol. Chem."},{"key":"60903_CR24","doi-asserted-by":"publisher","unstructured":"Lei, Y., Hu, Q. & Gu, J. Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance. Pathology oncology research: POR, https:\/\/doi.org\/10.1007\/s12253-019-00708-y (2019).","DOI":"10.1007\/s12253-019-00708-y"},{"key":"60903_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12020-013-9939-5","volume":"44","author":"K Esposito","year":"2013","unstructured":"Esposito, K. et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocr. 44, 634\u2013647, https:\/\/doi.org\/10.1007\/s12020-013-9939-5 (2013).","journal-title":"Endocr."},{"key":"60903_CR26","doi-asserted-by":"publisher","first-page":"21660","DOI":"10.1073\/pnas.0911316106","volume":"106","author":"X Tong","year":"2009","unstructured":"Tong, X., Zhao, F., Mancuso, A., Gruber, J. J. & Thompson, C. B. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl Acad. Sci. USA 106, 21660\u201321665, https:\/\/doi.org\/10.1073\/pnas.0911316106 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60903_CR27","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.2337\/db11-0802","volume":"61","author":"MR Metukuri","year":"2012","unstructured":"Metukuri, M. R. et al. ChREBP mediates glucose-stimulated pancreatic beta-cell proliferation. Diabetes 61, 2004\u20132015, https:\/\/doi.org\/10.2337\/db11-0802 (2012).","journal-title":"Diabetes"},{"key":"60903_CR28","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1073\/pnas.1310779111","volume":"111","author":"Y Yu","year":"2014","unstructured":"Yu, Y., Maguire, T. G. & Alwine, J. C. ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells. Proc. Natl Acad. Sci. USA 111, 1951\u20131956, https:\/\/doi.org\/10.1073\/pnas.1310779111 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60903_CR29","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00125-012-2506-4","volume":"55","author":"N Poungvarin","year":"2012","unstructured":"Poungvarin, N. et al. Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity. Diabetologia 55, 1783\u20131796, https:\/\/doi.org\/10.1007\/s00125-012-2506-4 (2012).","journal-title":"Diabetologia"},{"key":"60903_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt, S. Y. & Vander Heiden, M. G. Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation. Annu. Rev. Cell Dev. Bi 27, 441\u2013464, https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237 (2011).","journal-title":"Annu. Rev. Cell Dev. Bi"},{"key":"60903_CR31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MGV Heiden","year":"2009","unstructured":"Heiden, M. G. V., Cantley, L. C. & Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Sci. 324, 1029\u20131033, https:\/\/doi.org\/10.1126\/science.1160809 (2009).","journal-title":"Sci."},{"key":"60903_CR32","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.2337\/db15-0239","volume":"64","author":"P Zhang","year":"2015","unstructured":"Zhang, P. et al. Induction of the ChREBPbeta Isoform Is Essential for Glucose-Stimulated beta-Cell Proliferation. Diabetes 64, 4158\u20134170, https:\/\/doi.org\/10.2337\/db15-0239 (2015).","journal-title":"Diabetes"},{"key":"60903_CR33","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1158\/1541-7786.Mcr-14-0106-T","volume":"12","author":"S Abbadi","year":"2014","unstructured":"Abbadi, S. et al. Glucose-6-phosphatase Is a Key Metabolic Regulator of Glioblastoma Invasion. Mol. Cancer Res. 12, 1547\u20131559, https:\/\/doi.org\/10.1158\/1541-7786.Mcr-14-0106-T (2014).","journal-title":"Mol. Cancer Res."},{"key":"60903_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrc2248","volume":"7","author":"M Lobrich","year":"2007","unstructured":"Lobrich, M. & Jeggo, P. A. The impact of a negligent G2\/M checkpoint on genomic instability and cancer induction. Nat. reviews. Cancer 7, 861\u2013869, https:\/\/doi.org\/10.1038\/nrc2248 (2007).","journal-title":"Nat. reviews. Cancer"},{"key":"60903_CR35","doi-asserted-by":"publisher","first-page":"76305","DOI":"10.18632\/oncotarget.19351","volume":"8","author":"L Yin","year":"2017","unstructured":"Yin, L., Chang, C. & Xu, C. G2\/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes. Oncotarget 8, 76305\u201376317, https:\/\/doi.org\/10.18632\/oncotarget.19351 (2017).","journal-title":"Oncotarget"},{"key":"60903_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.celrep.2015.08.068","volume":"13","author":"V Sarrazy","year":"2015","unstructured":"Sarrazy, V. et al. Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation. Cell Rep. 13, 132\u2013144, https:\/\/doi.org\/10.1016\/j.celrep.2015.08.068 (2015).","journal-title":"Cell Rep."},{"key":"60903_CR37","doi-asserted-by":"publisher","first-page":"14740","DOI":"10.1074\/jbc.RA118.004099","volume":"293","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice. J. Biol. Chem. 293, 14740\u201314757, https:\/\/doi.org\/10.1074\/jbc.RA118.004099 (2018).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"60903_CR38","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1080\/15384101.2018.1489182","volume":"17","author":"Silvia Ribback","year":"2018","unstructured":"Ribback, S. et al. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma. Cell cycle, 1-17, https:\/\/doi.org\/10.1080\/15384101.2018.1489182 (2018).","journal-title":"Cell Cycle"},{"key":"60903_CR39","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1038\/onc.2014.321","volume":"34","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Metabolic reprogramming during TGF beta 1-induced epithelial-to-mesenchymal transition. Oncogene 34, 3908\u20133916, https:\/\/doi.org\/10.1038\/onc.2014.321 (2015).","journal-title":"Oncogene"},{"key":"60903_CR40","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/labinvest.2014.114","volume":"94","author":"Y Lei","year":"2014","unstructured":"Lei, Y. et al. Expression and distribution of immunoglobulin G in the normal liver, hepatocarcinoma and postpartial hepatectomy liver. Laboratory investigation; a J. technical methods Pathol. 94, 1283\u20131295, https:\/\/doi.org\/10.1038\/labinvest.2014.114 (2014).","journal-title":"Laboratory investigation; a J. technical methods Pathol."},{"key":"60903_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ar.22641","volume":"296","author":"EC Jensen","year":"2013","unstructured":"Jensen, E. C. Quantitative analysis of histological staining and fluorescence using Image. J. Anat. Rec. 296, 378\u2013381, https:\/\/doi.org\/10.1002\/ar.22641 (2013).","journal-title":"J. Anat. Rec."},{"key":"60903_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10620-013-2969-2","volume":"59","author":"XD Huang","year":"2014","unstructured":"Huang, X. D. et al. Suppression of KIF3B Expression Inhibits Human Hepatocellular Carcinoma Proliferation. Dig. Dis. Sci. 59, 795\u2013806, https:\/\/doi.org\/10.1007\/s10620-013-2969-2 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"60903_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep21260","volume":"6","author":"F Liu","year":"2016","unstructured":"Liu, F. et al. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling. Sci. Rep. 6, 21260, https:\/\/doi.org\/10.1038\/srep21260 (2016).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60903-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60903-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60903-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:54:28Z","timestamp":1670313268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60903-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60903"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60903-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4233"}}